Top Markets
#1 GoPlus Security GoPlus Security +31.58%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.85%
#3 Tutorial Tutorial +18.60%
#4 Status Status +15.77%
#5 Pons Pons +14.32%
#6 Wrapped NXM Wrapped NXM +14.12%
#7 Verus Coin Verus Coin +12.97%
#8 o1.exchange o1.exchange +10.06%
#9 SkyAI SkyAI +9.28%
#10 DMT-NAT DMT-NAT +8.92%
Coin of the day
GoPlus Security GoPlus Security
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
PreveCeutical Medical Inc. PreveCeutical Medical Inc.

PreveCeutical Medical Inc.

PREV
Rang in Aktien #33931
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating... PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
Aktienkurs
$0.01100905
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$6.59M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-49.29%
Land
CA
Handel PreveCeutical Medical Inc. (PREV)

Kategorie

Healthcare
P/B-Verhältnis für PreveCeutical Medical Inc. (PREV)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von PreveCeutical Medical Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für PreveCeutical Medical Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE